microgynon®
Showing 1 - 8 of 8
Healthy Trial (BI 456906, Microgynon®)
Not yet recruiting
- Healthy
- BI 456906
- Microgynon®
- (no location specified)
Jun 14, 2023
Relapsing Multiple Sclerosis (RMS) Trial in Germany, Poland (Cladribine, Placebo, Microgynon®)
Active, not recruiting
- Relapsing Multiple Sclerosis (RMS)
- Cladribine
- +2 more
-
Bochum, Germany
- +6 more
Feb 8, 2022
Healthy Trial in Mannheim (Microgynon®, BI 425809)
Recruiting
- Healthy
- Microgynon®
- BI 425809
-
Mannheim, GermanyCRS Clinical Research Services Mannheim GmbH
Jan 30, 2023
Diabetes, Type 2 Trial in Berlin (Semaglutide 1.34 mg/mL, Semaglutide 3.0 mg/mL, NNC0480-0389 10 mg/mL)
Recruiting
- Diabetes Mellitus, Type 2
- Semaglutide 1.34 mg/mL
- +4 more
-
Berlin, GermanyNovo Nordisk Investigational Site
Jan 3, 2022
Diabetes, Diabetes, Type 2 Trial in Berlin (semaglutide, SNAC, Microgynon®)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- +2 more
-
Berlin, GermanyNovo Nordisk Investigational Site
Jun 6, 2017
Healthy Trial in Mannheim (faldaprevir, Microgynon®, BI 207127)
Terminated
- Healthy
- faldaprevir
- +2 more
-
Mannheim, Germany1241.31.2 Boehringer Ingelheim Investigational Site
Mar 16, 2016
Healthy Trial (Microgynon®, BI 1356)
Completed
- Healthy
- Microgynon®
- BI 1356
- (no location specified)
Jul 4, 2014